Belite Bio, Inc(NASDAQ:BLTE) 
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.
Website: https://belitebio.com/
Founded: 2016
IPO Price: $6 (Apr 29, 2022)
CEO / Founder: Dr. Tom Lin
Sector: Technology
Industry: General
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 64.00
H 64.12
L 55.00
C 56.90
V 100,768
10EMA 56.90
20EMA 56.90
60EMA 56.90
120EMA 56.90
250EMA 56.90